No Data
2024 Earnings Report
Tinavi Medical Technologies' Orthopedic Surgery Navigation System Gets China Registration Certificate
Tianzhihang (688277.SH): The orthopedic surgery navigation positioning system has obtained the medical instruments registration certificate.
On February 12, Gelonghui reported that Tianzhihang (688277.SH) announced that it recently received a medical instruments registration certificate issued by the National Medical Products Administration. Product name: Orthopedic Surgery Navigation and Positioning System. The orthopedic surgical robot is mainly used in joint replacement surgeries, spinal surgeries, and orthopedic trauma surgeries. The indications for the certified product cover cervical, thoracic, lumbar, sacral spinal surgeries across all segments, as well as trauma surgeries in areas such as the pelvis, hip joint, and limbs, as well as total knee and hip replacement surgeries. The acquisition of the above medical instruments registration certificate is beneficial for enriching the company's product variety and continuously meeting diverse needs.
2024 Annual Results Forecast
Tianzhihang (688277.SH): The forecasted loss for the year 2024 is between 0.104 billion yuan and 0.13 billion yuan.
On January 24, Gelonghui reported that Tianzhihang (688277.SH) announced a performance forecast for 2024. According to preliminary calculations by the financial department, it is expected that the operating revenue for 2024 will be between 160 million yuan and 192 million yuan, a decrease of 8.59% to 23.82% compared to the same period last year. The net income attributable to the parent company's owners for 2024 is expected to be a loss of 104 million yuan to a loss of 130 million yuan, which is a decrease in losses of 26.3867 million yuan to 52.3867 million yuan compared to the same period last year, narrowing the loss by 16.8%.
Tianzhihang (688277.SH) subsidiary Anhui Aishirui plans to introduce two investors through equity financing.
Tianzhihang (688277.SH) announced that to promote the rapid development of its holding subsidiary Anhui Aishirui, An...
Tinavi Medical Technologies Co.,Ltd.'s (SHSE:688277) 26% Share Price Plunge Could Signal Some Risk
